Immuno-oncology
Recognizing that the pathology community needs to stay current about immuno-oncology (I-O) biomarker testing, ASCP organized a series of Learning Collaborative meetings with pathologists and laboratory professionals in 2024-2025. These meetings allowed pathologists and laboratory professionals to discuss ways to ensure that I-O biomarker testing is being performed effectively. These four resource guides were developed from the collective input and insights generated from the 2024-2025 ASCP Learning Collaborative discussions.
Share your feedback on the guides here.
These resource guides were supported by an independent educational grant from Bristol Myers Squibb.
This resource is designed to help pathologists, laboratory professionals, and other members of the cancer care team improve the use of PD-L1 testing in patients with cancer.
Provided by the American Society for Clinical Pathology in partnership with Clinical Care Options, LLC. This activity is supported by an educational grant from Lilly.